Usana Health Sciences Inc
USNAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Usana Health Sciences Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Jan 3, 2026. The latest insider filing shown is dated Jun 18, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| LOS ANGELES CAPITAL MANAGEMENT LLC | 2026-03-31 | 87 | $1.52K | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2026-03-31 | 43,005 | $751K | SEC filing |
| Invesco Ltd. | 2026-03-31 | 40,301 | $704K | SEC filing |
| Dynamic Technology Lab Private Ltd | 2026-03-31 | 15,035 | $263K | SEC filing |
| Bank of New York Mellon Corp | 2026-03-31 | 52,536 | $918K | SEC filing |
| MetLife Investment Management, LLC | 2026-03-31 | 5,819 | $102K | SEC filing |
| GSA CAPITAL PARTNERS LLP | 2026-03-31 | 16,044 | Not shown | SEC filing |
| Parallel Advisors, LLC | 2026-03-31 | 777 | $13.6K | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 98,367 | $1.72M | SEC filing |
| Key Financial Inc | 2026-03-31 | 200 | $3.49K | SEC filing |
| Rockefeller Capital Management L.P. | 2026-03-31 | 5 | $87 | SEC filing |
| LAZARD ASSET MANAGEMENT LLC | 2026-03-31 | 72,395 | $1.26M | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 3,796 | $66.3K | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 4,801 | $83.9K | SEC filing |
| NATIONAL BANK OF CANADA /FI/ | 2026-03-31 | 1,974 | $34.5K | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 91,149 | $1.59M | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 1,190,416 | $20.8M | SEC filing |
| Investors Portfolio Services LLC | 2026-03-31 | 79 | $1.39K | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 357 | $6.24K | SEC filing |
| Tidal Investments LLC | 2026-03-31 | 15,525 | $271K | SEC filing |
- Each value is checked against Usana Health Sciences Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Usana Health Sciences Inc's share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Usana Health Sciences Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-05-28 · Jones Paul A.: Larger than all 29 other insider sales of Common Stock on file. SEC filing
- 2025-05-27 · Noot Walter: Larger than 28 of the 29 other insider sales of Common Stock on file. SEC filing
- 2025-03-12 · Foukas Joshua: Larger than 27 of the 29 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-16 | Neidig Brent · CHIEF COMMERCIAL OFFICER | Common Stock | S — Open market or private sale | −5,002 | 19.45 | SEC filing |
| 2026-06-15 | Neidig Brent · CHIEF COMMERCIAL OFFICER | Common Stock | S — Open market or private sale | −909 | 20.01 | SEC filing |
| 2026-06-12 | Neidig Brent · CHIEF COMMERCIAL OFFICER | Common Stock | S — Open market or private sale | −1,602 | 20.15 | SEC filing |
| 2026-06-08 | Jones Paul A. · CHIEF PEOPLE OFFICER | Common Stock | S — Open market or private sale | −5,561 | 18.50 | SEC filing |
| 2026-06-01 | Fleming John Turman · Director | Common Stock | S — Open market or private sale | −2,450 | 17.93 | SEC filing |
| 2026-05-28 | Jones Paul A. · CHIEF PEOPLE OFFICER | Common Stock | S — Open market or private sale | −6,813 | 18.95 | SEC filing |
| 2026-05-27 | IIEKKING G DOUG · CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −5,360 | 18.75 | SEC filing |
| 2026-05-22 | FULLER GILBERT A · Director | Common Stock | S — Open market or private sale | −1,057 | 18.66 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-07 | FULLER GILBERT A · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +6,527 | SEC filing |
| 2026-05-07 | Ding Xia · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +6,527 | SEC filing |
| 2026-05-07 | Winssinger Frederic J · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +6,527 | SEC filing |
| 2026-05-07 | Fleming John Turman · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +6,527 | SEC filing |
| 2026-05-07 | Pelosi Peggie · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +6,527 | SEC filing |
| 2026-05-07 | WOOD TIMOTHY E · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +6,527 | SEC filing |
| 2026-05-07 | Nixon J Scott · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +6,527 | SEC filing |
| 2026-04-23 | WOOD TIMOTHY E · Director | Common Stock | M — Exercise or conversion of derivative security | +1,057 | SEC filing |
Showing 8 of 32 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.